Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01182831 |
Recruitment Status
: Unknown
Verified August 2010 by Asian Institute of Gastroenterology, India.
Recruitment status was: Recruiting
First Posted
: August 17, 2010
Last Update Posted
: August 30, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pancreatic Cancer | Procedure: percutaneous fluoro guided celiac plexus neurolysis Procedure: EUS guided neurolysis | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Randomized Trial Comparing Fluoroscopy Guided Percutaneous Technique Versus Endoscopic Ultrasound Guided Technique of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas |
Study Start Date : | January 2010 |
Estimated Primary Completion Date : | January 2011 |
Estimated Study Completion Date : | January 2011 |

Arm | Intervention/treatment |
---|---|
Active Comparator: percutaneous fluoro guided celiac plexus neurolysis |
Procedure: percutaneous fluoro guided celiac plexus neurolysis
It is percutaneous injection of neurolytic agent in and around the celiac ganglion
|
Active Comparator: EUS guided neurolysis |
Procedure: EUS guided neurolysis
It is injection of neurolytic agent in and around the celiac ganglion using an echo endoscope.
|
- immediate pain relief [ Time Frame: day of block to six months of follow-up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- all patients with carcinoma pancreas
Exclusion Criteria:
- patients below 18 years of age and who have not given consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01182831
India | |
Asian Institute of Gastroenterology | Recruiting |
Hyderabad, Andhra pradesh, India, 500034 | |
Contact: Santosh darisetty, MD +914023378888 ext 413 sant_dari@yahoo.com | |
Contact: srikar darisetty, MD +914023378888 srikar.darisetty@gmail.com |
Responsible Party: | Dr.Santosh Darisetty, Asian Institute of Gastroenterology |
ClinicalTrials.gov Identifier: | NCT01182831 History of Changes |
Other Study ID Numbers: |
AIG-GIA-201001 |
First Posted: | August 17, 2010 Key Record Dates |
Last Update Posted: | August 30, 2010 |
Last Verified: | August 2010 |
Keywords provided by Asian Institute of Gastroenterology, India:
carcinoma pancreas percutaneous celiac plexus neurolysis endosonography guided celiac plexus neurolysis |
Additional relevant MeSH terms:
Carcinoma Pancreatic Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Digestive System Neoplasms Neoplasms by Site |
Endocrine Gland Neoplasms Digestive System Diseases Pancreatic Diseases Endocrine System Diseases Pancrelipase Pancreatin Gastrointestinal Agents |